Cystatin C is a superior biomarker for assessing kidney function and Chronic Kidney Disease (CKD), offering greater accuracy than traditional kidney markers like creatinine. Unlike creatinine, Cystatin C is unaffected by muscle mass, diet, sex, race, or physical activity.1-3 Creatinine levels often remain normal until about 50% of kidney function is lost.4 This lack of sensitivity to mild renal insufficiency creates a "creatinine blind area", that can lead to under diagnosis of early CKD (stages 1 and 2).5
Combining creatinine and cystatin C values improves eGFR accuracy over using either marker alone.6-8 This integration enhances risk stratification for CKD patients, facilitates better resource allocation, such as nephrology referrals, medication dosage adjustments, and more comprehensive kidney function tests.9 Additionally, the combination strengthens the correlation between estimated GFR and risks like cardiovascular disease, end-stage renal disease progression, and mortality.10
Clinical use of cystatin C is recommended by the guidelines of the international organization KDIGO’s (Kidney Disease: Improving Global Outcomes). In the United States, the joint task force convened by the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) to address the race disparity in people with CKD, similarly advocates for expanded use of cystatin C, alongside creatinine, to confirm eGFR and enhance clinical decision-making.
Both the KDIGO guidelines and the NKF-ASN task force recommendations for managing CKD, advocate for a more substantial role for cystatin C, alongside creatinine, in estimating GFR. They emphasize the necessity of employing the most precise GFR assessment, often achieved through a combination of creatinine and cystatin C when mGFR is not a desired option.
The Gentian Cystatin C Immunoassay (ERM-DA471/IFCC standardized) is a turbidimetric test for quantitative determination of cystatin C in human serum and plasma.
The open channel test that can be added to all major clinical chemistry analyzers.
Does your organisation intend to perform for more than 1000 cystatin C tests per year on a clinical chemistry instrument with turbidimetric capabilities? If yes, contact us for a free* validation kit through the contact form below or send an email to marketing@gentian.com.
Explore cystatin C in your clinical practice and laboratory - fill out the form or send an email to marketing@gentian.com for more information about the product, prices and free validation kit*
*Terms and conditions:
Sole Discretion. Gentian Diagnostics shall, in its sole and absolute discretion, determine whether or not to proceed with all or part of the offer, determine the distribution date and determine whether to modify or change terms of the offer, including, without limitation, the form, structure and terms of any transaction(s) to affect the offer or the timing of and conditions to the consummation of the offer.
Contingency. The offer of a free validation kit is contingent on (a) the Customer providing written and/or verbal confirmation of an intent to perform for more than 200 cystatin C tests per annum on clinical chemistry system with turbidimetric capabilities and (b) the Customer agreeing to share all data pertaining experiments conducted to evaluate performance of the Gentian Cystatin C Immunoassay.
This website may contain information about products that are not registered for use in your country of residence and may not comply with applicable laws or regulations in that country. We do not take any responsibility for accessing such information in those circumstances.